Association of Bone Mineral Density and Bone Turnover Markers with the Risk of Diabetes : Hong Kong Osteoporosis Study and Mendelian Randomization

© 2023 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR)..

Preclinical studies demonstrated that bone plays a central role in energy metabolism. However, how bone metabolism is related to the risk of diabetes in humans is unknown. We investigated the association of bone health (bone mineral density [BMD] and bone turnover markers) with incident type-2 diabetes mellitus (T2DM) based on the Hong Kong Osteoporosis Study (HKOS). A total of 993 and 7160 participants from the HKOS were studied for the cross-sectional and prospective analyses, respectively. The cross-sectional study evaluated the association of BMD and bone biomarkers with fasting glucose and glycated hemoglobin (HbA1c ) levels, whereas the prospective study examined the associations between BMD at study sites and the risk of T2DM by following subjects a median of 16.8 years. Body mass index (BMI) was adjusted in all full models. Mendelian randomization (MR) was conducted for causal inference. In the cross-sectional analysis, lower levels of circulating bone turnover markers and higher BMD were significantly associated with increased fasting glucose and HbA1c levels. In the prospective analysis, higher BMD (0.1 g/cm2 ) at the femoral neck and total hip was associated with increased risk of T2DM with hazard ratios (HRs) of 1.10 (95% confidence interval [CI], 1.03 to 1.18) and 1.14 (95% CI, 1.08 to 1.21), respectively. The presence of osteoporosis was associated with a 30% reduction in risk of T2DM compared to those with normal BMD (HR = 0.70; 95% CI, 0.55 to 0.90). The MR results indicate a robust genetic causal association of estimated BMD (eBMD) with 2-h glucose level after an oral glucose challenge test (estimate = 0.043; 95% CI, 0.007 to 0.079) and T2DM (odds ratio = 1.064; 95% CI, 1.036 to 1.093). Higher BMD and lower levels of circulating bone biomarkers were cross-sectionally associated with poor glycemic control. Moreover, higher BMD was associated with a higher risk of incident T2DM and the association is probably causal. © 2023 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:38

Enthalten in:

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research - 38(2023), 12 vom: 01. Dez., Seite 1782-1790

Sprache:

Englisch

Beteiligte Personen:

Zhang, Xiaowen [VerfasserIn]
Krishnamoorthy, Suhas [VerfasserIn]
Tang, Casey Tze-Lam [VerfasserIn]
Hsu, Warrington Wen-Qiang [VerfasserIn]
Li, Gloria Hoi-Yee [VerfasserIn]
Sing, Chor-Wing [VerfasserIn]
Tan, Kathryn Choon-Beng [VerfasserIn]
Cheung, Bernard Man-Yung [VerfasserIn]
Wong, Ian Chi-Kei [VerfasserIn]
Kung, Annie Wai-Chee [VerfasserIn]
Cheung, Ching-Lung [VerfasserIn]

Links:

Volltext

Themen:

BONE MINERAL DENSITY
BONE TURNOVER MARKERS
Biomarkers
DIABETES
EPIDEMIOLOGY
Glucose
Glycated Hemoglobin
IY9XDZ35W2
Journal Article
MENDELIAN RANDOMIZATION
Minerals
OSTEOPOROSIS
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 28.12.2023

Date Revised 11.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/jbmr.4924

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM363433309